Compare · ATLN vs BRKR
ATLN vs BRKR
Side-by-side comparison of Atlantic International Corp. (ATLN) and Bruker Corporation (BRKR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATLN and BRKR operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- BRKR is the larger of the two at $9.02B, about 123.3x ATLN ($73.2M).
- Over the past year, ATLN is down 50.9% and BRKR is up 43.4% - BRKR leads by 94.3 points.
- ATLN has been more active in the news (11 items in the past 4 weeks vs 3 for BRKR).
- BRKR has more recent analyst coverage (22 ratings vs 0 for ATLN).
- Company
- Atlantic International Corp.
- Bruker Corporation
- Price
- $0.90-5.48%
- $58.22-1.79%
- Market cap
- $73.2M
- $9.02B
- 1M return
- -38.55%
- +4.37%
- 1Y return
- -50.91%
- +43.43%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 11
- 3
- Recent ratings
- 0
- 22
Bruker Corporation
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Latest ATLN
- Circle8 Awarded Two $20 Million Dutch Public Sector Contract Extensions, Demonstrating Positive Commercial Momentum Across the Public Sector
- Chairman & CEO Franke Guus Paul Wilhelm sold $308,783 worth of shares (308,783 units at $1.00), decreasing direct ownership by 2% to 12,207,287 units (SEC Form 4)
- SEC Form 424B3 filed by Atlantic International Corp.
- Atlantic International's Circle8 Awarded $175 Million Contract Extension From the Dutch Ministry Of Infrastructure (Rijkswaterstaat)
- Atlantic International Relaunches As Circle8, Reflecting Its Evolution Into A Global Technology and Workforce Solutions Platform
- Atlantic International Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Atlantic International Corp Regains Compliance With Nasdaq Listing Requirements
- SEC Form 424B3 filed by Atlantic International Corp.
- Atlantic International’s Circle8 Secures Minimum $52 Million Government Contract Award
- Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million
Latest BRKR
- EXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19 and sold $120,500 worth of shares (2,000 units at $60.25) as part of a pre-agreed trading plan (SEC Form 4)
- Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
- New insider Pusch Wolfgang claimed ownership of 10,154 shares (SEC Form 3)
- EXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19 and sold $109,520 worth of shares (2,000 units at $54.76) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-3ASR filed by Bruker Corporation
- Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
- Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
- Wolfe Research resumed coverage on Bruker
- Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
- SEC Form SD filed by Bruker Corporation